Uncommon Human Telomerase Reverse Transcriptase Promoter Mutations Are Associated With Poor Survival in Ovarian Clear Cell Carcinoma

International patterns and trends in ovarian cancer incidence, overall and by histologic subtype

(2017) S.B. Coburn et al.   INTERNATIONAL JOURNAL OF CANCER

The Dualistic Model of Ovarian Carcinogenesis

(2016) Robert J. Kurman et al.   AMERICAN JOURNAL OF PATHOLOGY

Inactivating ARID1A Tumor Suppressor EnhancesTERTTranscription and Maintains Telomere Length in Cancer Cells

(2016) Yohan Suryo Rahmanto et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene

(2016) Muhammad Ramlee et al.   Genes

Cancer-Specific Telomerase Reverse Transcriptase (TERT) Promoter Mutations: Biological and Clinical Implications

(2016) Tiantian Liu et al.   Genes

ARID1Aexpression in ovarian clear cell carcinoma with an adenofibromatous component

(2015) Kyoko Nishikimi et al.   HISTOPATHOLOGY

Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation

(2015) Yinghui Li et al.   NATURE CELL BIOLOGY

The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer

(2015) R. J. A. Bell et al.   SCIENCE

Cancer-associated TERT promoter mutations abrogate telomerase silencing

(2015) Kunitoshi Chiba et al.   eLife

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors

(2014) Tiantian Liu et al.   ENDOCRINE-RELATED CANCER

Recurrent TERT promoter mutations in non-small cell lung cancers

(2014) Xiao Ma et al.   LUNG CANCER

Combined analysis of TERT, EGFR, and IDH status defines distinct prognostic glioblastoma classes

(2014) M. Labussiere et al.   NEUROLOGY

TERT promoter mutation in resectable hepatocellular carcinomas: A strong association with hepatitis C infection and absence of hepatitis B infection

(2014) Yu-Ling Chen et al.   International Journal of Surgery

TERT Promoter Mutations Occur Early in Urothelial Neoplasia and Are Biomarkers of Early Disease and Disease Recurrence in Urine

(2013) I. Kinde et al.   CANCER RESEARCH

Comprehensive Mutation Analysis of the TERT Promoter in Bladder Cancer and Detection of Mutations in Voided Urine

(2013) Carolyn D. Hurst et al.   EUROPEAN UROLOGY

Frequent somatic mutations of the telomerase reverse transcriptase promoter in ovarian clear cell carcinoma but not in other major types of gynaecological malignancy

(2013) Ren-Chin Wu et al.   JOURNAL OF PATHOLOGY

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

(2013) Stig E Bojesen et al.   NATURE GENETICS

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism

(2013) P. S. Rachakonda et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

(2013) P. J. Killela et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

TERT Promoter Mutations in Familial and Sporadic Melanoma

(2013) S. Horn et al.   SCIENCE

Highly Recurrent TERT Promoter Mutations in Human Melanoma

(2013) F. W. Huang et al.   SCIENCE

High frequency of telomerase reverse-transcriptase promoter somatic mutations in hepatocellular carcinoma and preneoplastic lesions

(2013) Jean Charles Nault et al.   Nature Communications

Loss of ARID1A Expression Is an Early Molecular Event in Tumor Progression From Ovarian Endometriotic Cyst to Clear Cell and Endometrioid Carcinoma

(2012) Ayse Ayhan et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Pathogenesis of Ovarian Clear Cell Adenofibroma, Atypical Proliferative (Borderline) Tumor, and Carcinoma: Clinicopathologic Features of Tumors with Endometriosis or Adenofibromatous Components Support Two Related Pathways of Tumor Development

(2012) Chengquan Zhao et al.   Journal of Cancer

Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma

(2011) Elisabetta Kuhn et al.   MODERN PATHOLOGY

Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations

(2011) Sohei Yamamoto et al.   MODERN PATHOLOGY

ARID1AMutations in Endometriosis-Associated Ovarian Carcinomas

(2010) Kimberly C. Wiegand et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cystic and Adenofibromatous Clear Cell Carcinomas of the Ovary

(2009) Emanuela Veras et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Ets2 Maintains hTERT Gene Expression and Breast Cancer Cell Proliferation by Interacting with c-Myc

(2008) Dakang Xu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY